Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats-Reference-Cited by-同舟云学术

Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats

Published:2011-07 Issue:2-3 Volume:204 Page:134-140
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Kannen Vinicius,Marini Tassiana,Turatti Aline,Carvalho Milene C.,Brandão Marcus L.,Jabor Valquiria A.P.,Bonato Pierina S.,Ferreira Frederico R.,Zanette Dalila L.,Silva Wilson A.,Garcia Sérgio B.

Funder

CAPES

CNPq

FAPESP

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference48 articles.

1. Intracellular cAMP and calcium signaling by serotonin in mouse cumulus-oocyte complexes;Amireault;Mol. Pharmacol.,2005

2. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma;Arends;J. Pathol.,1986

3. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells;Arimochi;Eur. J. Pharmacol.,2006

4. Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumors;Barkla;J. Natl. Cancer Inst.,1981

5. Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse;Bertrand;Am. J. Physiol. Gastrointest. Liver Physiol.,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual dimorphism in colorectal cancer: molecular mechanisms and treatment strategies;Biology of Sex Differences;2024-06-12

2. Drug Repurposing: Exploring Potential Anti-Cancer Strategies by Targeting Cancer Signalling Pathways;Biology;2024-05-28

3. Serotonin Receptor HTR2B Facilitates Colorectal Cancer Metastasis via CREB1–ZEB1 Axis–Mediated Epithelial–Mesenchymal Transition;Molecular Cancer Research;2024-02-21

4. The application of antidepressant drugs in cancer treatment;Biomedicine & Pharmacotherapy;2023-01

5. Use of Selective Serotonin Reuptake Inhibitors Is Associated with a Lower Risk of Colorectal Cancer among People with Family History;Cancers;2022-11-29